Pages that link to "Q48454595"
Jump to navigation
Jump to search
The following pages link to Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study (Q48454595):
Displaying 35 items.
- Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder (Q26823991) (← links)
- Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder (Q28252973) (← links)
- Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect (Q28267032) (← links)
- Midline and right frontal brain function as a physiologic biomarker of remission in major depression (Q29399995) (← links)
- Telemonitoring with respect to mood disorders and information and communication technologies: overview and presentation of the PSYCHE project (Q30434498) (← links)
- Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression (Q30488794) (← links)
- The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data. (Q30825123) (← links)
- Biomarkers to predict antidepressant response (Q34247513) (← links)
- Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder (Q35153746) (← links)
- Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. (Q35237042) (← links)
- Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments (Q35547596) (← links)
- Cortical functional activity in patients with generalized anxiety disorder (Q36070148) (← links)
- Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence (Q37522358) (← links)
- The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants. (Q37812199) (← links)
- Surrogate markers of treatment outcome in major depressive disorder (Q37911004) (← links)
- Electroencephalogram-based pharmacodynamic measures: a review (Q37989009) (← links)
- Electrocortical features of depression and their clinical utility in assessing antidepressant treatment outcome (Q38149983) (← links)
- EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response (Q38154919) (← links)
- Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? (Q38864824) (← links)
- The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder (Q39122800) (← links)
- Changes in brain function during administration of venlafaxine or placebo to normal subjects (Q40023174) (← links)
- Neural Network Based Response Prediction of rTMS in Major Depressive Disorder Using QEEG Cordance (Q41451392) (← links)
- How can we realize the promise of personalized antidepressant medicines? (Q44045526) (← links)
- Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? (Q44126419) (← links)
- Analysis of Brain Functional Changes in High-Frequency Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression (Q44970723) (← links)
- Targeting remission by 8 weeks: when should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor? (Q45333645) (← links)
- Treatment Results of Anorexia Nervosa and Bulimia Nervosa in a Residential Treatment Program (Q45815797) (← links)
- Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years (Q47666907) (← links)
- Alpha Wavelet Power as a Biomarker of Antidepressant Treatment Response in Bipolar Depression. (Q47910495) (← links)
- QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder. (Q48317822) (← links)
- Comment on ‘The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants’ (Q48642530) (← links)
- Association study of theta EEG asymmetry and brain-derived neurotrophic factor gene variants in childhood-onset mood disorder (Q51889844) (← links)
- Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis (Q57033193) (← links)
- QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response (Q58721391) (← links)
- Depression and Sleep (Q64272939) (← links)